Tecnifar-Industria Tecnica Farmaceutica, S.A.;Technophage; Investigacao E Desenvolvimento Em Biotecnologia; SA;Technophage, Investigacao E Desenvolvimento Em Biotecnologia, SA
发明人:
Da Costa Garcia, Miguel Angelo,Sousa De Sao Jose, Carlos Jorge,Rodrigues Leandro, Clara Isabel,Rodrigues Pardal Dias Antunes Marcal Da Silva, Filipa Maria,Ferreira Llorente Grancho Lourenco, Sara
申请号：
AU2010211456
公开号：
AU2010211456B2
申请日:
2010.02.05
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections. In particular, the present invention is directed to the novel bacteriophages F1245/05, F168/08, F170/08, F770/05, F197/08, F86/06, F87s/06 and F91a/06, isolated polypeptides thereof, compositions comprising one or more of the novel bacteriophages and/or isolated polypeptides and methods for the treatment and prevention of bacterial infection, either alone or in combination with other antibacterial therapies, e.g., antibiotics or other phage therapies.
